Received Jul 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y015179 | — |
No side effects reported; HCP is calling report an AE for a patient that received fourth dosage of GARDASIL 9 on 04/28/2025. No side effects reported. No additional details provided. No additional AE/PQC reported.; This spontaneous report was received from a Registered Nurse and refers to a 19-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 28-Apr-2025, the patient was vaccinated with a fourth dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #Y015179, expiration date: 28-Jan-2027), dose number 1 for prophylaxis (extra dose administered). No adverse event was reported.